Therapeutic miRNA-Enriched Extracellular Vesicles: Current Approaches and Future Prospects

Area of Science:

• Biotechnology
• Cell Biology
• Drug Delivery

Background:

• Extracellular vesicles (EVs) are nanoscale vesicles secreted by cells, carrying molecular cargo like microRNAs (miRNAs).
• EVs mediate intercellular communication by transferring functional miRNAs to recipient cells, altering their biological functions.
• The drug delivery field is exploring EVs for targeted delivery of therapeutic miRNAs due to their biocompatibility and targeting potential.

Purpose of the Study:

• To review the progress in the development of therapeutic miRNA-enriched EVs.
• To identify key research areas and challenges for clinical translation.
• To discuss the future potential of EVs as carriers for miRNA-based therapeutics.

Main Methods:

• Literature review focusing on recent advancements in EV engineering for miRNA enrichment.
• Analysis of studies investigating the therapeutic efficacy and safety of miRNA-enriched EVs.
• Discussion of current obstacles in EV production, loading, and clinical application.

Main Results:

• EVs can be engineered to carry specific therapeutic miRNAs, enabling targeted delivery.
• EVs demonstrate potential in modulating recipient cell behavior for disease treatment.
• Significant challenges remain in large-scale production, purification, and clinical validation of miRNA-enriched EVs.

Conclusions:

• Therapeutic miRNA-enriched EVs represent a promising frontier in targeted therapy.
• Further research is crucial to overcome existing hurdles for clinical implementation.
• Optimizing EV engineering and understanding their in vivo behavior are key for future success.